"The survey is still open and we have expanded the number of questions we are asking; we need more responses in relation to the type of funding model and whether or not you you understand what we are trying to do."
"Please note although we are going with the Charcot 2 Project we are still working on the HSCT vs. Alemtuzumab or the ZEUS study. At the moment we are engaging with Dr Paolo Muraro's group at Imperial who will need to lead on this."
"This remains a community project so please feel free to comment. Thank you."
CoI: multiple